No Insurance Required!
Click to Sign Up Today

A local research site is enrolling healthy adults 50–64 years old for a clinical research study evaluating an investigational, variant-adapted COVID-19 vaccine. You may qualify if you are between 50 and 64 and in generally good health.

Landing page image

Research Study for Adults Ages 50–64

COVID-19 Vaccine Research Study

Research Study for Adults Ages 50–64

A local research site is enrolling healthy adults 50–64 years old for a clinical research study evaluating an investigational, variant-adapted COVID-19 vaccine.

You may qualify if you are between 50 and 64 and in generally good health.

Landing page image

Participants Receive

Study-related medical care at no cost
Study-related investigational medication at no cost
Reimbursement for time and travel expenses

Participants Receive

Asset 1

Study-related medical care at no cost

Asset 2

Study-related investigational medication at no cost

Asset 3

Reimbursement for time and travel expenses

You May Qualify If

You are 50–64 years old
You are in generally good health
You have not tested positive for COVID-19 in the past 90 days
You have not received any COVID-19 vaccine in the past 90 day
You have not taken antiviral treatment for COVID-19 (e.g., Paxlovid) in the past 90 days

Why COVID-19 Vaccine Research Research Matters

COVID-19 continues to evolve, and updated vaccines are being developed to better match circulating variants. Research like this helps scientists learn how well newer formulations may work in healthy adults without underlying high-risk conditions.

By participating, you can help advance the understanding of COVID-19 prevention and contribute to the development of updated vaccine options.

Help Advance COVID-19 Vaccine Research

Elixia Health is seeking volunteers ages 50–64 to take part in a research study evaluating an investigational COVID-19 vaccine designed to help researchers better understand protection against circulating variants.

By joining, you’ll receive study-related care at no cost and play an important role in supporting research that may guide future COVID-19 vaccination strategies.

Why Join a Clinical Research Study
• Receive study-related care from qualified professionals
• Support the development of future vaccine options
• Contribute to important public health research
• Compensation may be provided for time and participate

Elixia’s Commitment to Our Research Studies
At Elixia, we are dedicated to advancing vaccine research through carefully conducted clinical research studies. Our mission is to help support the development of innovative treatment options for COVID-19.

You May Qualify If

  • You are 50–64 years old
  • You are in generally good health
  • You have not tested positive for COVID-19 in the past 90 days
  • You have not received any COVID-19 vaccine in the past 90 day
  • You have not taken antiviral treatment for COVID-19 (e.g., Paxlovid) in the past 90 days

To see if you are eligible, please complete the form to get in touch with the study team.

Elixia AI Coordinator Widget

Current Study Locations

No results found.